Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 6, 2014, Pages 817-830

  Bursac, Sladana ^a   Brdovcak, Maja Cokaric ^a   Donati, Giulio ^b   Volarevic, Sinisa ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

5S rRNA; P53; Ribosome biogenesis stress; Ribosomopathies; RPL11; RPL5

Indexed keywords

PROTEIN MDM2; PROTEIN P53; RIBOSOMAL PROTEIN L11; RIBOSOMAL PROTEIN L5; RIBOSOME PROTEIN; RNA 5S; UNCLASSIFIED DRUG; MDM2 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

BIOGENESIS; CELL CULTURE; DEGRADATION; DNA DAMAGE; DNA DAMAGE CHECKPOINT; DOWNSTREAM PROCESSING; GENE ACTIVATION; HETEROZYGOTE; HUMAN; IN VIVO STUDY; MALIGNANT TRANSFORMATION; NEDDYLATION; NONHUMAN; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RIBOSOME; SHWACHMAN SYNDROME; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UPREGULATION; GENETICS; METABOLISM; NUCLEOLUS; PROTEIN SYNTHESIS; TRANSCRIPTION INITIATION;

CELL NUCLEOLUS; DNA DAMAGE; HUMANS; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-MDM2; RIBOSOMAL PROTEINS; RIBOSOMES; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84897077346     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.08.014     Document Type: Review

References (225)

1. Budkevich T.V., El'skaya A.V., Nierhaus K.H. Features of 80S mammalian ribosome and its subunits. Nucleic Acids Res. 2008, 36:4736-4744.
2. Wool I.G., Chan Y.L., Gluck A. Structure and evolution of mammalian ribosomal proteins. Biochem. Cell Biol. 1995, 73:933-947.
3. Rudra D., Warner J.R. What better measure than ribosome synthesis?. Gene Dev. 2004, 18:2431-2436.
4. Schmidt E.V. The role of c-myc in cellular growth control. Oncogene 1999, 18:2988-2996.
5. Sulic S., Panic L., Dikic I., Volarevic S. Deregulation of cell growth and malignant transformation. Croat. Med. J. 2005, 46:622-638.
6. Thomas G. An encore for ribosome biogenesis in the control of cell proliferation. Nat. Cell Biol. 2000, 2:E71-E72.
7. Henras A.K., Soudet J., Gerus M., Lebaron S., Caizergues-Ferrer M., Mougin A., Henry Y. The post-transcriptional steps of eukaryotic ribosome biogenesis. Cell. Mol. Life Sci. 2008, 65:2334-2359.
8. Lewis J.D., Tollervey D. Like attracts like: getting RNA processing together in the nucleus. Sci. (New York, N.Y.) 2000, 288:1385-1389.
9. Tschochner H., Hurt E. Pre-ribosomes on the road from the nucleolus to the cytoplasm. Trends Cell Biol. 2003, 13:255-263.
10. Ciganda M., Williams N. Eukaryotic 5S rRNA biogenesis. Wiley Interdiscip. Rev. 2011, 2:523-533.
11. Ferreira-Cerca S., Poll G., Gleizes P.E., Tschochner H., Milkereit P. Roles of eukaryotic ribosomal proteins in maturation and transport of pre-18S rRNA and ribosome function. Mol. Cell 2005, 20:263-275.
12. Hu H., Li X. Transcriptional regulation in eukaryotic ribosomal protein genes. Genomics 2007, 90:421-423.
13. Loreni F., Iadevaia V., Tino E., Caldarola S., Amaldi F. RACK1 mRNA translation is regulated via a rapamycin-sensitive pathway and coordinated with ribosomal protein synthesis. FEBS Lett. 2005, 579:5517-5520.
14. O'Donohue M.F., Choesmel V., Faubladier M., Fichant G., Gleizes P.E. Functional dichotomy of ribosomal proteins during the synthesis of mammalian 40S ribosomal subunits. J. Cell Biol. 2010, 190:853-866.
15. Robledo S., Idol R.A., Crimmins D.L., Ladenson J.H., Mason P.J., Bessler M. The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA (New York, N.Y.) 2008, 14:1918-1929.
16. Draptchinskaia N., Gustavsson P., Andersson B., Pettersson M., Willig T.N., Dianzani I., Ball S., Tchernia G., Klar J., Matsson H., Tentler D., Mohandas N., Carlsson B., Dahl N. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat. Genet. 1999, 21:169-175.
17. Volarevic S., Stewart M.J., Ledermann B., Zilberman F., Terracciano L., Montini E., Grompe M., Kozma S.C., Thomas G. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Sci. (New York, N.Y.) 2000, 288:2045-2047.
18. Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature 2009, 461:1071-1078.
19. Deisenroth C., Zhang Y. Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway. Oncogene 2010, 29:4253-4260.
20. Pestov D.G., Strezoska Z., Lau L.F. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol. Cell. Biol. 2001, 21:4246-4255.
21. Sulic S., Panic L., Barkic M., Mercep M., Uzelac M., Volarevic S. Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. Gene Dev. 2005, 19:3070-3082.
22. Zhang Y., Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009, 16:369-377.
23. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
24. Zilfou J.T., Lowe S.W. Tumor suppressive functions of p53. Cold Spring Harb. Perspect. Biol. 2009, 1.
25. Levine A.J., Oren M. The first 30years of p53: growing ever more complex. Nat. Rev. 2009, 9:749-758.
26. Robles A.I., Harris C.C. Clinical outcomes and correlates of TP53 mutations and cancer. Cold Spring Harb. Perspect. Biol. 2010, 2:a001016.
27. Lai K., Amsterdam A., Farrington S., Bronson R.T., Hopkins N., Lees J.A. Many ribosomal protein mutations are associated with growth impairment and tumor predisposition in zebrafish. Dev. Dyn. 2009, 238:76-85.
28. Vlachos A., Rosenberg P.S., Atsidaftos E., Alter B.P., Lipton J.M. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood 2012, 119:3815-3819.
29. Panic L., Montagne J., Cokaric M., Volarevic S. S6-haploinsufficiency activates the p53 tumor suppressor. Cell Cycle (Georgetown, Tex) 2007, 6:20-24.
30. Macias E., Jin A., Deisenroth C., Bhat K., Mao H., Lindstrom M.S., Zhang Y. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell 2010, 18:231-243.
31. Barkic M., Crnomarkovic S., Grabusic K., Bogetic I., Panic L., Tamarut S., Cokaric M., Jeric I., Vidak S., Volarevic S. The p53 tumor suppressor causes congenital malformations in Rpl24-deficient mice and promotes their survival. Mol. Cell. Biol. 2009, 29:2489-2504.
32. McGowan K.A., Li J.Z., Park C.Y., Beaudry V., Tabor H.K., Sabnis A.J., Zhang W., Fuchs H., de Angelis M.H., Myers R.M., Attardi L.D., Barsh G.S. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat. Genet. 2008, 40:963-970.
33. Narla A., Ebert B.L. Ribosomopathies: human disorders of ribosome dysfunction. Blood 2010, 115:3196-3205.
34. Panic L., Tamarut S., Sticker-Jantscheff M., Barkic M., Solter D., Uzelac M., Grabusic K., Volarevic S. Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation. Mol. Cell. Biol. 2006, 26:8880-8891.
35. Teng T., Thomas G., Mercer C.A. Growth control and ribosomopathies. Curr. Opin. Genet. Dev. 2013, 23:63-71.
36. Yuan X., Zhou Y., Casanova E., Chai M., Kiss E., Grone H.J., Schutz G., Grummt I. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol. Cell 2005, 19:77-87.
37. Rubbi C.P., Milner J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 2003, 22:6068-6077.
38. Donati G., Bertoni S., Brighenti E., Vici M., Trere D., Volarevic S., Montanaro L., Derenzini M. The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. Oncogene 2011, 30:3274-3288.
39. Huang M., Ji Y., Itahana K., Zhang Y., Mitchell B. Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption. Leuk. Res. 2008, 32:131-141.
40. Sun X.X., Dai M.S., Lu H. Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11. J. Biol. Chem. 2008, 283:12387-12392.
41. Waddington C.H., Perry M.M. Helical arrangement of ribosomes in differentiating muscle cells. Exp. Cell Res. 1963, 30:599-600.
42. Bywater M.J., Poortinga G., Sanij E., Hein N., Peck A., Cullinane C., Wall M., Cluse L., Drygin D., Anderes K., Huser N., Proffitt C., Bliesath J., Haddach M., Schwaebe M.K., Ryckman D.M., Rice W.G., Schmitt C., Lowe S.W., Johnstone R.W., Pearson R.B., McArthur G.A., Hannan R.D. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 2012, 22:51-65.
43. Longley D.B., Harkin D.P., Johnston P.G. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. 2003, 3:330-338.
44. Sun X.X., Dai M.S., Lu H. 5-Fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction. J. Biol. Chem. 2007, 282:8052-8059.
45. Holzel M., Rohrmoser M., Schlee M., Grimm T., Harasim T., Malamoussi A., Gruber-Eber A., Kremmer E., Hiddemann W., Bornkamm G.W., Eick D. Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required for ribosome biogenesis and cell proliferation. J. Cell Biol. 2005, 170:367-378.
46. Yu W., Qiu Z., Gao N., Wang L., Cui H., Qian Y., Jiang L., Luo J., Yi Z., Lu H., Li D., Liu M. PAK1IP1, a ribosomal stress-induced nucleolar protein, regulates cell proliferation via the p53-MDM2 loop. Nucleic Acids Res. 2010, 39:2234-2248.
47. McMahon M., Ayllon V., Panov K.I., O'Connor R. Ribosomal 18S RNA processing by the IGF-I-responsive WDR3 protein is integrated with p53 function in cancer cell proliferation. J. Biol. Chem. 2010, 285:18309-18318.
48. Skarie J.M., Link B.A. The primary open-angle glaucoma gene WDR36 functions in ribosomal RNA processing and interacts with the p53 stress-response pathway. Hum. Mol. Genet. 2008, 17:2474-2485.
49. Kurki S., Peltonen K., Latonen L., Kiviharju T.M., Ojala P.M., Meek D., Laiho M. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 2004, 5:465-475.
50. Dai M.S., Sun X.X., Lu H. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol. Cell. Biol. 2008, 28:4365-4376.
51. Fumagalli S., Di Cara A., Neb-Gulati A., Natt F., Schwemberger S., Hall J., Babcock G.F., Bernardi R., Pandolfi P.P., Thomas G. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat. Cell Biol. 2009, 11:501-508.
52. Lindstrom M.S., Nister M. Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation. PLoS ONE 2010, 5:e9578.
53. Bursac S., Brdovcak M.C., Pfannkuchen M., Orsolic I., Golomb L., Zhu Y., Katz C., Daftuar L., Grabusic K., Vukelic I., Filic V., Oren M., Prives C., Volarevic S. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:20467-20472.
54. Fumagalli S., Ivanenkov V.V., Teng T., Thomas G. Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Gene Dev. 2012, 26:1028-1040.
55. Jin A., Itahana K., O'Keefe K., Zhang Y. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol. Cell. Biol. 2004, 24:7669-7680.
56. Sun X.X., Wang Y.G., Xirodimas D.P., Dai M.S. Perturbation of 60S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation. J. Biol. Chem. 2010, 285:25812-25821.
57. Llanos S., Serrano M. Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway. Cell Cycle (Georgetown, Tex) 2010, 9:4005-4012.
58. Dutt S., Narla A., Lin K., Mullally A., Abayasekara N., Megerdichian C., Wilson F.H., Currie T., Khanna-Gupta A., Berliner N., Kutok J.L., Ebert B.L. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 2011, 117:2567-2576.
59. Zhou X., Hao Q., Liao J., Zhang Q., Lu H. Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene 2013, 32:388-396.
60. Daftuar L., Zhu Y., Jacq X., Prives C. Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network. PLoS ONE 2013, 8:e68667.
61. Golomb L., Bublik D.R., Wilder S., Nevo R., Kiss V., Grabusic K., Volarevic S., Oren M. Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis. Mol. Cell 2012, 45:222-232.
62. Anderson S.J., Lauritsen J.P., Hartman M.G., Foushee A.M., Lefebvre J.M., Shinton S.A., Gerhardt B., Hardy R.R., Oravecz T., Wiest D.L. Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint. Immunity 2007, 26:759-772.
63. Terzian T., Dumble M., Arbab F., Thaller C., Donehower L.A., Lozano G., Justice M.J., Roop D.R., Box N.F. Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models. J. Pathol. 2011, 224:540-552.
64. Sherr C.J. Tumor surveillance via the ARF-p53 pathway. Gene Dev. 1998, 12:2984-2991.
65. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
66. Toledo F., Wahl G.M. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. 2006, 6:909-923.
67. Shvarts A., Steegenga W.T., Riteco N., van Laar T., Dekker P., Bazuine M., van Ham R.C., van der Houven W., van Oordt G., van der Hateboer A.J., Eb A.G.Jochemsen MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J. 1996, 15:5349-5357.
68. Kruse J.P., Gu W. Modes of p53 regulation. Cell 2009, 137:609-622.
69. Gu J., Kawai H., Nie L., Kitao H., Wiederschain D., Jochemsen A.G., Parant J., Lozano G., Yuan Z.M. Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. J. Biol. Chem. 2002, 277:19251-19254.
70. Wang X., Wang J., Jiang X. MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination. J. Biol. Chem. 2011, 286:23725-23734.
71. Tollini L.A., Zhang Y. p53 regulation goes live - Mdm2 and MdmX co-star: lessons learned from mouse modeling. Genes Cancer 2012, 3:219-225.
72. Hock A.K., Vousden K.H. The role of ubiquitin modification in the regulation of p53. Biochim. Biophys. Acta 2014, 1843:137-149.
73. Hu W., Feng Z., Levine A.J. The regulation of multiple p53 stress responses is mediated through MDM2. Genes Cancer 2012, 3:199-208.
74. Meek D.W. Tumour suppression by p53: a role for the DNA damage response?. Nat. Rev. 2009, 9:714-723.
75. Kawai H., Wiederschain D., Kitao H., Stuart J., Tsai K.K., Yuan Z.M. DNA damage-induced MDMX degradation is mediated by MDM2. J. Biol. Chem. 2003, 278:45946-45953.
76. Biderman L., Poyurovsky M.V., Assia Y., Manley J.L., Prives C. MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress. Mol. Cell. Biol. 2012, 32:1214-1225.
77. Chen L., Gilkes D.M., Pan Y., Lane W.S., Chen J. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J. 2005, 24:3411-3422.
78. Halazonetis T.D., Gorgoulis V.G., Bartek J. An oncogene-induced DNA damage model for cancer development. Sci. (New York, N.Y.) 2008, 319:1352-1355.
79. Palmero I., Pantoja C., Serrano M. p19ARF links the tumour suppressor p53 to Ras. Nature 1998, 395:125-126.
80. Zindy F., Eischen C.M., Randle D.H., Kamijo T., Cleveland J.L., Sherr C.J., Roussel M.F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Gene Dev. 1998, 12:2424-2433.
81. Bates S., Phillips A.C., Clark P.A., Stott F., Peters G., Ludwig R.L., Vousden K.H. p14ARF links the tumour suppressors RB and p53. Nature 1998, 395:124-125.
82. de Stanchina E., McCurrach M.E., Zindy F., Shieh S.Y., Ferbeyre G., Samuelson A.V., Prives C., Roussel M.F., Sherr C.J., Lowe S.W. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Gene Dev. 1998, 12:2434-2442.
83. Damalas A., Kahan S., Shtutman M., Ben-Ze'ev A., Oren M. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J. 2001, 20:4912-4922.
84. Zimmerman R.S., Rosenberg N. Changes in p19Arf localization accompany apoptotic crisis during pre-B-cell transformation by Abelson murine leukemia virus. J. Virol. 2008, 82:8383-8391.
85. Honda R., Yasuda H. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 1999, 18:22-27.
86. Lowe S.W., Sherr C.J. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 2003, 13:77-83.
87. Sherr C.J. Divorcing ARF and p53: an unsettled case. Nat. Rev. 2006, 6:663-673.
88. Llanos S., Clark P.A., Rowe J., Peters G. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat. Cell Biol. 2001, 3:445-452.
89. Pan Y., Chen J. MDM2 promotes ubiquitination and degradation of MDMX. Mol. Cell. Biol. 2003, 23:5113-5121.
90. Marechal V., Elenbaas B., Piette J., Nicolas J.C., Levine A.J. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell. Biol. 1994, 14:7414-7420.
91. Lohrum M.A., Ludwig R.L., Kubbutat M.H., Hanlon M., Vousden K.H. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003, 3:577-587.
92. Zhang Y., Wolf G.W., Bhat K., Jin A., Allio T., Burkhart W.A., Xiong Y. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol. Cell. Biol. 2003, 23:8902-8912.
93. Dai M.S., Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem. 2004, 279:44475-44482.
94. Zhou X., Liao J.M., Liao W.J., Lu H. Scission of the p53-MDM2 loop by ribosomal proteins. Genes Cancer 2012, 3:298-310.
95. Deisenroth C., Zhang Y. Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway. Oncogene 2010, 29:4253-4260.
96. Dai M.S., Zeng S.X., Jin Y., Sun X.X., David L., Lu H. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol. Cell. Biol. 2004, 24:7654-7668.
97. Ofir-Rosenfeld Y., Boggs K., Michael D., Kastan M.B., Oren M. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol. Cell 2008, 32:180-189.
98. Zhang Y., Wang J., Yuan Y., Zhang W., Guan W., Wu Z., Jin C., Chen H., Zhang L., Yang X., He F. Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26. Nucleic Acids Res. 2010, 38:6544-6554.
99. Yadavilli S., Mayo L.D., Higgins M., Lain S., Hegde V., Deutsch W.A. Ribosomal protein S3: a multi-functional protein that interacts with both p53 and MDM2 through its KH domain. DNA Repair 2009, 8:1215-1224.
100. Chen D., Zhang Z., Li M., Wang W., Li Y., Rayburn E.R., Hill D.L., Wang H., Zhang R. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 2007, 26:5029-5037.
101. Zhu Y., Poyurovsky M.V., Li Y., Biderman L., Stahl J., Jacq X., Prives C. Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol. Cell 2009, 35:316-326.
102. Zhang X., Wang W., Wang H., Wang M.H., Xu W., Zhang R. Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop. Oncogene 2013, 32:2782-2791.
103. Sun X.X., DeVine T., Challagundla K.B., Dai M.S. Interplay between ribosomal protein S27a and MDM2 protein in p53 activation in response to ribosomal stress. J. Biol. Chem. 2011, 286:22730-22741.
104. Xiong X., Zhao Y., He H., Sun Y. Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis as a target, a substrate and a regulator. Oncogene 2011, 30:1798-1811.
105. Warner J.R. In the absence of ribosomal RNA synthesis, the ribosomal proteins of HeLa cells are synthesized normally and degraded rapidly. J. Mol. Biol. 1977, 115:315-333.
106. Donati G., Peddigari S., Mercer C.A., Thomas G. 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint. Cell Rep. 2013, 4:87-98.
107. Volarevic S., Thomas G. Role of S6 phosphorylation and S6 kinase in cell growth. Prog. Nucleic Acid Res. Mol. Biol. 2001, 65:101-127.
108. Lam Y.W., Lamond A.I., Mann M., Andersen J.S. Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr. Biol. 2007, 17:749-760.
109. Andersen J.S., Lam Y.W., Leung A.K., Ong S.E., Lyon C.E., Lamond A.I., Mann M. Nucleolar proteome dynamics. Nature 2005, 433:77-83.
110. Tsvetkov P., Reuven N., Shaul Y. The nanny model for IDPs. Nat. Chem. Biol. 2009, 5:778-781.
111. Li M., Gu W. A critical role for noncoding 5S rRNA in regulating Mdmx stability. Mol. Cell 2011, 43:1023-1032.
112. Horn H.F., Vousden K.H. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene 2008, 27:5774-5784.
113. Gilkes D.M., Chen L., Chen J. MDMX regulation of p53 response to ribosomal stress. EMBO J. 2006, 25:5614-5625.
114. Zhang J., Harnpicharnchai P., Jakovljevic J., Tang L., Guo Y., Oeffinger M., Rout M.P., Hiley S.L., Hughes T., Woolford J.L. Assembly factors Rpf2 and Rrs1 recruit 5S rRNA and ribosomal proteins rpL5 and rpL11 into nascent ribosomes. Gene Dev. 2007, 21:2580-2592.
115. Sasaki M., Kawahara K., Nishio M., Mimori K., Kogo R., Hamada K., Itoh B., Wang J., Komatsu Y., Yang Y.R., Hikasa H., Horie Y., Yamashita T., Kamijo T., Zhang Y., Zhu Y., Prives C., Nakano T., Mak T.W., Sasaki T., Maehama T., Mori M., Suzuki A. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat. Med. 2011, 17:944-951.
116. Yim J.H., Kim Y.J., Ko J.H., Cho Y.E., Kim S.M., Kim J.Y., Lee S., Park J.H. The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death. Cell Death Differ. 2007, 14:1872-1879.
117. Merritt M.A., Parsons P.G., Newton T.R., Martyn A.C., Webb P.M., Green A.C., Papadimos D.J., Boyle G.M. Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer. BMC Cancer 2009, 9:378.
118. Kim Y.J., Cho Y.E., Kim Y.W., Kim J.Y., Lee S., Park J.H. Suppression of putative tumour suppressor gene GLTSCR2 expression in human glioblastomas. J. Pathol. 2008, 216:218-224.
119. Cairncross J.G., Ueki K., Zlatescu M.C., Lisle D.K., Finkelstein D.M., Hammond R.R., Silver J.S., Stark P.C., Macdonald D.R., Ino Y., Ramsay D.A., Louis D.N. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J. Natl. Cancer Inst. 1998, 90:1473-1479.
120. Mariani L., Deiana G., Vassella E., Fathi A.R., Murtin C., Arnold M., Vajtai I., Weis J., Siegenthaler P., Schobesberger M., Reinert M.M. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy. J. Clin. Oncol. 2006, 24:4758-4763.
121. Smith J.S., Alderete B., Minn Y., Borell T.J., Perry A., Mohapatra G., Hosek S.M., Kimmel D., O'Fallon J., Yates A., Feuerstein B.G., Burger P.C., Scheithauer B.W., Jenkins R.B. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 1999, 18:4144-4152.
122. Sundqvist A., Liu G., Mirsaliotis A., Xirodimas D.P. Regulation of nucleolar signalling to p53 through NEDDylation of L11. EMBO Rep. 2009, 10:1132-1139.
123. Ito A., Lai C.H., Zhao X., Saito S., Hamilton M.H., Appella E., Yao T.P. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J. 2001, 20:1331-1340.
124. Mahata B., Sundqvist A., Xirodimas D.P. Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner. Oncogene 2013, 31:3060-3071.
125. Kuroda T., Murayama A., Katagiri N., Ohta Y.M., Fujita E., Masumoto H., Ema M., Takahashi S., Kimura K., Yanagisawa J. RNA content in the nucleolus alters p53 acetylation via MYBBP1A. EMBO J. 2011, 30:1054-1066.
126. Condemine W., Takahashi Y., Le Bras M., de The H. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells. J. Cell Sci. 2007, 120:3219-3227.
127. Donati G., Montanaro L., Derenzini M. Ribosome biogenesis and control of cell proliferation: p53 is not alone. Cancer Res. 2012, 72:1602-1607.
128. Ganguli G., Wasylyk B. p53-independent functions of MDM2. Mol. Cancer Res. 2003, 1:1027-1035.
129. Manfredi J.J. The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. Gene Dev. 2010, 24:1580-1589.
130. Donati G., Brighenti E., Vici M., Mazzini G., Trere D., Montanaro L., Derenzini M. Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. J. Cell Sci. 2011, 124:3017-3028.
131. Oskarsson T., Trumpp A. The Myc trilogy: lord of RNA polymerases. Nat. Cell Biol. 2005, 7:215-217.
132. van Riggelen J., Felsher D.W. Myc and a Cdk2 senescence switch. Nat. Cell Biol. 2010, 12:7-9.
133. Challagundla K.B., Sun X.X., Zhang X., DeVine T., Zhang Q., Sears R.C., Dai M.S. Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress. Mol. Cell. Biol. 2011, 31:4007-4021.
134. Dai M.S., Arnold H., Sun X.X., Sears R., Lu H. Inhibition of c-Myc activity by ribosomal protein L11. EMBO J. 2007, 26:3332-3345.
135. Dai M.S., Sun X.X., Lu H. Ribosomal protein L11 associates with c-Myc at 5S rRNA and tRNA genes and regulates their expression. J. Biol. Chem. 2010, 285:12587-12594.
136. Hinnebusch A.G. Active destruction of defective ribosomes by a ubiquitin ligase involved in DNA repair. Gene Dev. 2009, 23:891-895.
137. McIntosh K.B., Bhattacharya A., Willis I.M., Warner J.R. Eukaryotic cells producing ribosomes deficient in Rpl1 are hypersensitive to defects in the ubiquitin-proteasome system. PLoS ONE 2011, 6:e23579.
138. Helmrich A., Ballarino M., Tora L. Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol. Cell 2011, 44:966-977.
139. Wahba L., Amon J.D., Koshland D., Vuica-Ross M. RNase H and multiple RNA biogenesis factors cooperate to prevent RNA:DNA hybrids from generating genome instability. Mol. Cell 2011, 44:978-988.
140. Boisvert F.M., van Koningsbruggen S., Navascues J., Lamond A.I. The multifunctional nucleolus. Nat. Rev. Mol. Cell Biol. 2007, 8:574-585.
141. Hage A.E., Tollervey D. A surfeit of factors: why is ribosome assembly so much more complicated in eukaryotes than bacteria?. RNA Biol. 2004, 1:10-15.
142. Dez C., Houseley J., Tollervey D. Surveillance of nuclear-restricted pre-ribosomes within a subnucleolar region of Saccharomyces cerevisiae. EMBO J. 2006, 25:1534-1546.
143. Fujii K., Kitabatake M., Sakata T., Miyata A., Ohno M. A role for ubiquitin in the clearance of nonfunctional rRNAs. Gene Dev. 2009, 23:963-974.
144. LaRiviere F.J., Cole S.E., Ferullo D.J., Moore M.J. A late-acting quality control process for mature eukaryotic rRNAs. Mol. Cell 2006, 24:619-626.
145. Kraft C., Deplazes A., Sohrmann M., Peter M. Mature ribosomes are selectively degraded upon starvation by an autophagy pathway requiring the Ubp3p/Bre5p ubiquitin protease. Nat. Cell Biol. 2008, 10:602-610.
146. Ruggero D., Pandolfi P.P. Does the ribosome translate cancer?. Nat. Rev. 2003, 3:179-192.
147. Levine B., Abrams J. p53: the Janus of autophagy?. Nat. Cell Biol. 2008, 10:637-639.
148. Scherz-Shouval R., Weidberg H., Gonen C., Wilder S., Elazar Z., Oren M. p53-Dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:18511-18516.
149. Boisvert F.M., Lamond A.I. p53-Dependent subcellular proteome localization following DNA damage. Proteomics 2010, 10:4087-4097.
150. Mayne L.V., Lehmann A.R. Failure of RNA synthesis to recover after UV irradiation: an early defect in cells from individuals with Cockayne's syndrome and xeroderma pigmentosum. Cancer Res. 1982, 42:1473-1478.
151. Kruhlak M., Crouch E.E., Orlov M., Montano C., Gorski S.A., Nussenzweig A., Misteli T., Phair R.D., Casellas R. The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks. Nature 2007, 447:730-734.
152. Boyd M.T., Vlatkovic N., Rubbi C.P. The nucleolus directly regulates p53 export and degradation. J. Cell Biol. 2011, 194:689-703.
153. Bernardi R., Scaglioni P.P., Bergmann S., Horn H.F., Vousden K.H., Pandolfi P.P. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat. Cell Biol. 2004, 6:665-672.
154. Takagi M., Absalon M.J., McLure K.G., Kastan M.B. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 2005, 123:49-63.
155. Chen J., Kastan M.B. 5'-3'-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage. Gene Dev. 2012, 24:2146-2156.
156. Chen J., Guo K., Kastan M.B. Interactions of nucleolin and ribosomal protein L26 (RPL26) in translational control of human p53 mRNA. J. Biol. Chem. 2012, 287:16467-16476.
157. Itahana K., Bhat K.P., Jin A., Itahana Y., Hawke D., Kobayashi R., Zhang Y. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol. Cell 2003, 12:1151-1164.
158. Sugimoto M., Kuo M.L., Roussel M.F., Sherr C.J. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol. Cell 2003, 11:415-424.
159. Ayrault O., Andrique L., Fauvin D., Eymin B., Gazzeri S., Seite P. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation. Oncogene 2006, 25:7577-7586.
160. Lessard F., Morin F., Ivanchuk S., Langlois F., Stefanovsky V., Rutka J., Moss T. The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I. Mol. Cell 2010, 38:539-550.
161. Morton J.P., Kantidakis T., White R.J. RNA polymerase III transcription is repressed in response to the tumour suppressor ARF. Nucleic Acids Res. 2007, 35:3046-3052.
162. Dai M.S., Challagundla K.B., Sun X.X., Palam L.R., Zeng S.X., Wek R.C., Lu H. Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF. J. Biol. Chem. 2012, 287:17120-17129.
163. Fregoso O.I., Das S., Akerman M., Krainer A.R. Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence. Mol. Cell 2013, 50:56-66.
164. T.T.C.S.C.Group Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. The Treacher Collins Syndrome Collaborative Group. Nat. Genet. 1996, 12:130-136.
165. Hayano T., Yanagida M., Yamauchi Y., Shinkawa T., Isobe T., Takahashi N. Proteomic analysis of human Nop56p-associated pre-ribosomal ribonucleoprotein complexes. Possible link between Nop56p and the nucleolar protein treacle responsible for Treacher Collins syndrome. J. Biol. Chem. 2003, 278:34309-34319.
166. Valdez B.C., Henning D., So R.B., Dixon J., Dixon M.J. The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10709-10714.
167. Jones N.C., Lynn M.L., Gaudenz K., Sakai D., Aoto K., Rey J.P., Glynn E.F., Ellington L., Du C., Dixon J., Dixon M.J., Trainor P.A. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat. Med. 2008, 14:125-133.
168. Choesmel V., Fribourg S., Aguissa-Toure A.H., Pinaud N., Legrand P., Gazda H.T., Gleizes P.E. Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder. Hum. Mol. Genet. 2008, 17:1253-1263.
169. Cmejla R., Cmejlova J., Handrkova H., Petrak J., Petrtylova K., Mihal V., Stary J., Cerna Z., Jabali Y., Pospisilova D. Identification of mutations in the ribosomal protein L5 (RPL5) and ribosomal protein L11 (RPL11) genes in Czech patients with Diamond-Blackfan anemia. Hum. Mutat. 2009, 30:321-327.
170. Cmejla R., Cmejlova J., Handrkova H., Petrak J., Pospisilova D. Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia. Hum. Mutat. 2007, 28:1178-1182.
171. Quarello P., Garelli E., Carando A., Brusco A., Calabrese R., Dufour C., Longoni D., Misuraca A., Vinti L., Aspesi A., Biondini L., Loreni F., Dianzani I., Ramenghi U. Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations. Haematologica 2010, 95:206-213.
172. Doherty L., Sheen M.R., Vlachos A., Choesmel V., O'Donohue M.F., Clinton C., Schneider H.E., Sieff C.A., Newburger P.E., Ball S.E., Niewiadomska E., Matysiak M., Glader B., Arceci R.J., Farrar J.E., Atsidaftos E., Lipton J.M., Gleizes P.E., Gazda H.T. Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia. Am. J. Hum. Genet. 2010, 86:222-228.
173. Farrar J.E., Nater M., Caywood E., McDevitt M.A., Kowalski J., Takemoto C.M., Talbot C.C., Meltzer P., Esposito D., Beggs A.H., Schneider H.E., Grabowska A., Ball S.E., Niewiadomska E., Sieff C.A., Vlachos A., Atsidaftos E., Ellis S.R., Lipton J.M., Gazda H.T., Arceci R.J. Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood 2008, 112:1582-1592.
174. Farrar J.E., Vlachos A., Atsidaftos E., Carlson-Donohoe H., Markello T.C., Arceci R.J., Ellis S.R., Lipton J.M., Bodine D.M. Ribosomal protein gene deletions in Diamond-Blackfan anemia. Blood 2011, 118:6943-6951.
175. Gazda H.T., Grabowska A., Merida-Long L.B., Latawiec E., Schneider H.E., Lipton J.M., Vlachos A., Atsidaftos E., Ball S.E., Orfali K.A., Niewiadomska E., Da Costa L., Tchernia G., Niemeyer C., Meerpohl J.J., Stahl J., Schratt G., Glader B., Backer K., Wong C., Nathan D.G., Beggs A.H., Sieff C.A. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am. J. Hum. Genet. 2006, 79:1110-1118.
176. Gazda H.T., Sheen M.R., Vlachos A., Choesmel V., O'Donohue M.F., Schneider H., Darras N., Hasman C., Sieff C.A., Newburger P.E., Ball S.E., Niewiadomska E., Matysiak M., Zaucha J.M., Glader B., Niemeyer C., Meerpohl J.J., Atsidaftos E., Lipton J.M., Gleizes P.E., Beggs A.H. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am. J. Hum. Genet. 2008, 83:769-780.
177. Quarello P., Garelli E., Brusco A., Carando A., Mancini C., Pappi P., Vinti L., Svahn J., Dianzani I., Ramenghi U. High frequency of ribosomal protein gene deletions in Italian Diamond-Blackfan anemia patients detected by multiplex ligation-dependent probe amplification assay. Haematologica 2012, 97:1813-1817.
178. Kuramitsu M., Sato-Otsubo A., Morio T., Takagi M., Toki T., Terui K., Wang R., Kanno H., Ohga S., Ohara A., Kojima S., Kitoh T., Goi K., Kudo K., Matsubayashi T., Mizue N., Ozeki M., Masumi A., Momose H., Takizawa K., Mizukami T., Yamaguchi K., Ogawa S., Ito E., Hamaguchi I. Extensive gene deletions in Japanese patients with Diamond-Blackfan anemia. Blood 2012, 119:2376-2384.
179. Landowski M., O'Donohue M.F., Buros C., Ghazvinian R., Montel-Lehry N., Vlachos A., Sieff C.A., Newburger P.E., Niewiadomska E., Matysiak M., Glader B., Atsidaftos E., Lipton J.M., Beggs A.H., Gleizes P.E., Gazda H.T. Novel deletion of RPL15 identified by array-comparative genomic hybridization in Diamond-Blackfan anemia. Hum. Genet. 2013, 132:1265-1274.
180. Gazda H.T., Preti M., Sheen M.R., O'Donohue M.F., Vlachos A., Davies S.M., Kattamis A., Doherty L., Landowski M., Buros C., Ghazvinian R., Sieff C.A., Newburger P.E., Niewiadomska E., Matysiak M., Glader B., Atsidaftos E., Lipton J.M., Gleizes P.E., Beggs A.H. Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre-ribosomal RNA processing defect in diamond-blackfan anemia. Hum. Mutat. 2012, 33:1037-1044.
181. Angelini M., Cannata S., Mercaldo V., Gibello L., Santoro C., Dianzani I., Loreni F. Missense mutations associated with Diamond-Blackfan anemia affect the assembly of ribosomal protein S19 into the ribosome. Hum. Mol. Genet. 2007, 16:1720-1727.
182. Choesmel V., Bacqueville D., Rouquette J., Noaillac-Depeyre J., Fribourg S., Cretien A., Leblanc T., Tchernia G., Da Costa L., Gleizes P.E. Impaired ribosome biogenesis in Diamond-Blackfan anemia. Blood 2007, 109:1275-1283.
183. Flygare J., Aspesi A., Bailey J.C., Miyake K., Caffrey J.M., Karlsson S., Ellis S.R. Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood 2007, 109:980-986.
184. Idol R.A., Robledo S., Du H.Y., Crimmins D.L., Wilson D.B., Ladenson J.H., Bessler M., Mason P.J. Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. Blood Cells Mol. Dis. 2007, 39:35-43.
185. Matsson H., Davey E.J., Draptchinskaia N., Hamaguchi I., Ooka A., Leveen P., Forsberg E., Karlsson S., Dahl N. Targeted disruption of the ribosomal protein S19 gene is lethal prior to implantation. Mol. Cell. Biol. 2004, 24:4032-4037.
186. Jaako P., Flygare J., Olsson K., Quere R., Ehinger M., Henson A., Ellis S., Schambach A., Baum C., Richter J., Larsson J., Bryder D., Karlsson S. Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. Blood 2011, 118:6087-6096.
187. Danilova N., Sakamoto K.M., Lin S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 2008, 112:5228-5237.
188. Torihara H., Uechi T., Chakraborty A., Shinya M., Sakai N., Kenmochi N. Erythropoiesis failure due to RPS19 deficiency is independent of an activated Tp53 response in a zebrafish model of Diamond-Blackfan anaemia. Br. J. Haematol. 2011, 152:648-654.
189. Watkins-Chow D.E., Cooke J., Pidsley R., Edwards A., Slotkin R., Leeds K.E., Mullen R., Baxter L.L., Campbell T.G., Salzer M.C., Biondini L., Gibney G., Phan Dinh Tuy F., Chelly J., Morris H.D., Riegler J., Lythgoe M.F., Arkell R.M., Loreni F., Flint J., Pavan W.J., Keays D.A. Mutation of the Diamond-Blackfan anemia gene Rps7 in mouse results in morphological and neuroanatomical phenotypes. PLoS Genet. 2013, 9:e1003094.
190. Boultwood J., Fidler C., Strickson A.J., Watkins F., Gama S., Kearney L., Tosi S., Kasprzyk A., Cheng J.F., Jaju R.J., Wainscoat J.S. Narrowing and genomic annotation of the commonly deleted region of the 5q-syndrome. Blood 2002, 99:4638-4641.
191. Ebert B.L., Pretz J., Bosco J., Chang C.Y., Tamayo P., Galili N., Raza A., Root D.E., Attar E., Ellis S.R., Golub T.R. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature 2008, 451:335-339.
192. Barlow J.L., Drynan L.F., Hewett D.R., Holmes L.R., Lorenzo-Abalde S., Lane A.L., Jolin H.E., Pannell R., Middleton A.J., Wong S.H., Warren A.J., Wainscoat J.S., Boultwood J., McKenzie A.N. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome. Nat. Med. 2010, 16:59-66.
193. Starczynowski D.T., Kuchenbauer F., Argiropoulos B., Sung S., Morin R., Muranyi A., Hirst M., Hogge D., Marra M., Wells R.A., Buckstein R., Lam W., Humphries R.K., Karsan A. Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype. Nat. Med. 2010, 16:49-58.
194. Burwick N., Coats S.A., Nakamura T., Shimamura A. Impaired ribosomal subunit association in Shwachman-Diamond syndrome. Blood 2012, 120:5143-5152.
195. Finch A.J., Hilcenko C., Basse N., Drynan L.F., Goyenechea B., Menne T.F., Gonzalez Fernandez A., Simpson P., D'Santos C.S., Arends M.J., Donadieu J., Bellanne-Chantelot C., Costanzo M., Boone C., McKenzie A.N., Freund S.M., Warren A.J. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Gene Dev. 2011, 25:917-929.
196. Wong C.C., Traynor D., Basse N., Kay R.R., Warren A.J. Defective ribosome assembly in Shwachman-Diamond syndrome. Blood 2011, 118:4305-4312.
197. Provost E., Wehner K.A., Zhong X., Ashar F., Nguyen E., Green R., Parsons M.J., Leach S.D. Ribosomal biogenesis genes play an essential and p53-independent role in zebrafish pancreas development. Dev. (Cambridge, England) 2012, 139:3232-3241.
198. Moniz H., Gastou M., Leblanc T., Hurtaud C., Cretien A., Lecluse Y., Raslova H., Larghero J., Croisille L., Faubladier M., Bluteau O., Lordier L., Tchernia G., Vainchenker W., Mohandas N., Da Costa L. Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitro. Cell Death Dis. 2012, 3:e356.
199. Elghetany M.T., Alter B.P. p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia. Arch. Pathol. Lab. Med. 2002, 126:452-455.
200. Pellagatti A., Marafioti T., Paterson J.C., Barlow J.L., Drynan L.F., Giagounidis A., Pileri S.A., Cazzola M., McKenzie A.N., Wainscoat J.S., Boultwood J. Induction of p53 and up-regulation of the p53 pathway in the human 5q-syndrome. Blood 2010, 115:2721-2723.
201. Chakraborty A., Uechi T., Higa S., Torihara H., Kenmochi N. Loss of ribosomal protein L11 affects zebrafish embryonic development through a p53-dependent apoptotic response. PLoS ONE 2009, 4:e4152.
202. Lodish H.F. Model for the regulation of mRNA translation applied to haemoglobin synthesis. Nature 1974, 251:385-388.
203. Mamane Y., Petroulakis E., Rong L., Yoshida K., Ler L.W., Sonenberg N. eIF4E - from translation to transformation. Oncogene 2004, 23:3172-3179.
204. Rajasekhar V.K., Viale A., Socci N.D., Wiedmann M., Hu X., Holland E.C. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol. Cell 2003, 12:889-901.
205. Fumagalli S., Thomas G. The role of p53 in ribosomopathies. Semin. Hematol. 2011, 48:97-105.
206. Bellodi C., Kopmar N., Ruggero D. Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J. 2010, 29:1865-1876.
207. Horos R., Ijspeert H., Pospisilova D., Sendtner R., Andrieu-Soler C., Taskesen E., Nieradka A., Cmejla R., Sendtner M., Touw I.P., von Lindern M. Ribosomal deficiencies in Diamond-Blackfan anemia impair translation of transcripts essential for differentiation of murine and human erythroblasts. Blood 2012, 119:262-272.
208. Montanaro L., Trere D., Derenzini M. Nucleolus, ribosomes, and cancer. Am. J. Pathol. 2008, 173:301-310.
209. Mochizuki Y., He J., Kulkarni S., Bessler M., Mason P.J. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10756-10761.
210. Schmid P., Lorenz A., Hameister H., Montenarh M. Expression of p53 during mouse embryogenesis. Dev. (Cambridge, England) 1991, 113:857-865.
211. Johnson L.F., Levis R., Abelson H.T., Green H., Penman S. Changes in RNA in relation to growth of the fibroblast. IV. Alterations in the production and processing of mRNA and rRNA in resting and growing cells. J. Cell Biol. 1976, 71:933-938.
212. Bilanges B., Stokoe D. Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 2007, 26:5973-5990.
213. White R.J. RNA polymerases I and III, non-coding RNAs and cancer. Trends Genet. 2008, 24:622-629.
214. van Riggelen J., Yetil A., Felsher D.W. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat. Rev. 2010, 10:301-309.
215. Barna M., Pusic A., Zollo O., Costa M., Kondrashov N., Rego E., Rao P.H., Ruggero D. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 2008, 456:971-975.
216. Pan W., Issaq S., Zhang Y. The in vivo role of the RP-Mdm2-p53 pathway in signaling oncogenic stress induced by pRb inactivation and Ras overexpression. PLoS ONE 2011, 6:e21625.
217. Stewart M.J., Denell R. Mutations in the Drosophila gene encoding ribosomal protein S6 cause tissue overgrowth. Mol. Cell. Biol. 1993, 13:2524-2535.
218. Watson K.L., Konrad K.D., Woods D.F., Bryant P.J. Drosophila homolog of the human S6 ribosomal protein is required for tumor suppression in the hematopoietic system. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:11302-11306.
219. Amsterdam A., Sadler K.C., Lai K., Farrington S., Bronson R.T., Lees J.A., Hopkins N. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2004, 2:E139.
220. Berghmans S., Murphey R.D., Wienholds E., Neuberg D., Kutok J.L., Fletcher C.D., Morris J.P., Liu T.X., Schulte-Merker S., Kanki J.P., Plasterk R., Zon L.I., Look A.T. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:407-412.
221. MacInnes A.W., Amsterdam A., Whittaker C.A., Hopkins N., Lees J.A. Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10408-10413.
222. Mason P.J., Bessler M. The genetics of dyskeratosis congenita. Cancer Genet. 2011, 204:635-645.
223. Montanaro L., Calienni M., Bertoni S., Rocchi L., Sansone P., Storci G., Santini D., Ceccarelli C., Taffurelli M., Carnicelli D., Brigotti M., Bonafe M., Trere D., Derenzini M. Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. Cancer Res. 2010, 70:4767-4777.
224. Jadersten M., Saft L., Smith A., Kulasekararaj A., Pomplun S., Gohring G., Hedlund A., Hast R., Schlegelberger B., Porwit A., Hellstrom-Lindberg E., Mufti G.J. TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression. J. Clin. Oncol. 2011, 29:1971-1979.
225. Oren M., Rotter V. Mutant p53 gain-of-function in cancer. Cold Spring Harb. Perspect. Biol. 2010, 2:a001107.